Ignite Creation Date:
2024-05-06 @ 6:53 PM
Last Modification Date:
2024-10-26 @ 2:57 PM
Study NCT ID:
NCT05828303
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-11
First Post:
2023-03-28
Brief Title:
A Phase 1 Study to Evaluate the Potential Drug Interactions Between Repotrectinib and Metformin Digoxin and Rosuvastatin in Patients With Advanced Solid Tumors
Sponsor:
Turning Point Therapeutics Inc
Organization:
Turning Point Therapeutics Inc
Organization Data
Organization:
Turning Point Therapeutics Inc
Class:
INDUSTRY
Study ID:
CA127-1027
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Turning Point Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None